You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑞普生物(300119.SZ):子公司瑞普天津取得消毒產品生產企業衞生許可證
格隆匯 02-10 13:44

格隆匯2月10日丨瑞普生物(300119.SZ)宣佈,公司全資子公司瑞普(天津)生物藥業有限公司(簡稱“瑞普天津”),近日取得由天津市衞生健康委員會頒發的消毒產品生產企業衞生許可證。證書編號:(津)衞消證字(2021)第0582號;生產項目:消毒劑;有效期限:2021年2月3日至2025年2月2日。

瑞普天津生產的“瑞普力盾○R”(過硫酸氫鉀複合物粉)消毒劑屬於複合型消毒劑,加入水中後可以持續產生次氯酸、新生態氧,通過氯化、氧化、酸化三重殺滅病原微生物,包括對大腸桿菌、金黃色葡萄球菌、白色念珠菌等具有殺滅作用。該產品可用於家庭、辦公場所、醫院、廠房街道、物體表面等多種場合的環境消毒。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account